Recent News
On January 21, 2026 the company’s board declared a regular quarterly cash dividend of $0.12 per share, payable March 6, 2026 to shareholders of record on February 13, 2026.
Technical Analysis
Directional indicators (ADX / DI+ / DI-): ADX at 38.65 signals a strong trend environment; DI+ at 30.41 and increasing while DI- at 11.87 and decreasing together indicate bullish directional pressure that supports further upside versus the current valuation.
MACD & signal: MACD registers 2.33 with a MACD signal at 2.02, but MACD_trend shows a peak-and-reversal; the recent peak-and-reversal denotes bearish momentum emerging even though MACD currently sits just above its signal line, creating short-term conflict between signal-cross structure and momentum decay.
MRO (Momentum/Regression Oscillator): MRO at 25.02 sits positive, indicating price presently exceeds the model target and therefore carries downside potential back toward target levels; the MRO dip-and-reversal suggests the overshoot recently eased and the magnitude implies meaningful mean-reversion risk to watch against the bullish directional setup.
RSI: RSI at 62.83 and rising indicates bullish internals without being overbought; this supports continuation of gains while leaving room before typical overbought levels near 70.
Price vs moving averages, Bollinger, Ichimoku: Closing price $72.97 trades above the 20-day average $70.16, 50-day average $65.06, and 200-day average $60.35, and the 12-day EMA trend sits higher at $71.34 — a structure consistent with trend-following strength. Price sits near the upper 1x Bollinger band ($73.76), implying proximity to short-term resistance. Ichimoku Tenkan ($69.47) and Kijun ($68.36) below price reinforce bullish bias and near-term support levels.
Volatility & volume context: 42-day beta 0.53 and 52-week beta 0.90 reflect below-market to market-like sensitivity; recent volume (144,142) runs below 10- and 50-day averages, suggesting moves may lack heavy conviction from higher-volume participation.
Fundamental Analysis
Earnings and surprises: Reported EPS $1.27 versus an estimate $1.28 produced an EPS surprise of -0.78%, a modest miss that does not materially alter the broader earnings momentum profile.
Earnings trends: Earnings growth YoY reached 26.29%, while earnings growth QoQ shows +55.56%, indicating strong sequential and annual improvement in profitability metrics available for the reporting period ending 2025-12-31.
Revenue dynamics: Reported revenue growth figures indicate 0.0% year-over-year and a -100.0% reading on both QoQ and YoY growth metrics in the provided data; treat the -100.0% QoQ/YoY values as reported here rather than as interpretive trend statements.
Valuation multiples: Trailing PE at 49.33 and forward PE at 34.41 reflect premiumably higher multiples versus many smaller materials peers. WMDST values the stock as fair-valued. The company’s PEG stands at -2.73; that PEG sits above the industry peer mean of -10.13 and above the industry peer median of -12.02, closer to the industry peer high of 3.46. Trailing PE of 49.33 sits below the industry peer mean of 80.40 and slightly below the industry peer median of 54.30, indicating mixed relative multiple positioning within the peer range.
Capital & cost metrics: Invested capital totals $649,400,000 and reported cost of debt rounds to 1.07%. Cash-flow metrics show $0.0 reported cash conversion into the specific cash-flow fields provided; no additional cash conversion signal appears for analysis here.
Valuation summary: WMDST’s valuation marks the equity as fair-valued; multiples reflect a market pricing that rewards recent earnings recovery while pricing in execution risk from revenue dynamics and mean-reversion potential signaled by the MRO.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-12-31 |
| REPORT DATE: | 2026-01-29 |
| NEXT REPORT DATE: | 2026-04-30 |
| CASH FLOW | Begin Period Cash Flow | — |
| Operating Cash Flow | — | |
| Capital Expenditures | — | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | — | |
| End Period Cash Flow | — | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | $ 1.28 | |
| EPS Actual | $ 1.27 | |
| EPS Difference | $ -0.01 | |
| EPS Surprise | -0.781 % | |
| Forward EPS | $ 1.75 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | 49.334 | |
| Price To Earnings QoQ | 10.721 % | |
| Price To Earnings YoY | -3.744 % | |
| Price To Earnings IPRWA | high: 152.705 mean: 80.405 median: 54.302 MTX: 49.334 low: -19.937 |
|
| PE/G Ratio | -2.731 | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | 34.406 | |
| Forward PE/G | -1.905 | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | — | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | high: 328.394 median: 91.211 mean: 86.792 low: 60.923 MTX: 0 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ 649.4 M | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 1.071 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | 0.0 % | |
| Revenue Growth QoQ | -100.0 % | |
| Revenue Growth YoY | -100.0 % | |
| Revenue Growth IPRWA | high: 4.316 % MTX: 0.0 % median: -2.034 % mean: -3.261 % low: -9.644 % |
|
| Earnings Growth | -18.065 % | |
| Earnings Growth QoQ | 55.558 % | |
| Earnings Growth YoY | 2628.852 % | |
| Earnings Growth IPRWA | high: 15.686 % mean: -10.515 % MTX: -18.065 % median: -28.814 % low: -37.883 % |
|
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | — | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | — | |
| Free Cash Growth QoQ | — | |
| Free Cash Growth YoY | — | |
| Free Cash Growth IPRWA | — | |
| Free Cash To Net Income | — | |
| Cash Flow Margin | 0.0 % | |
| Cash Flow To Earnings | 0.0 | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |